CI: The Cigna Group Stock

SIC 6324 – Hospital and Medical Service Plans

Valuation
Market Cap ($M) 98,164.69
Enterprise Value ($M) 122,896.69
Book Value ($M) 46,351.00
Book Value / Share 163.41
Price / Book 2.12
NCAV ($M) -72,127.00
NCAV / Share -254.28
Price / NCAV -1.36

Profitability (mra)
Return on Invested Capital (ROIC) 0.07
Return on Assets (ROA) 0.03
Return on Equity (ROE) 0.12

Liquidity (mrq)
Quick Ratio 0.61
Current Ratio 0.74

Balance Sheet (mrq) ($M)
Current Assets 34,283.00
Assets 152,761.00
Liabilities 106,410.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 195,187.00
Operating Income 8,956.00
Net Income 5,164.00
Earnings Per Share Diluted n/a
Earnings Per Share Effect Of Dilution n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 11,813.00
Cash from Investing -5,174.00
Cash from Financing -4,294.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Vanguard Group Inc 8.47 -3.16
02-09 13G/A Fmr Llc 4.96 -10.65
01-25 13G/A BlackRock Inc. 8.40 -10.61

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S
2023-05-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-18 233,177 1,381,812 16.87
2024-04-17 184,216 1,238,886 14.87
2024-04-16 250,808 1,799,903 13.93
2024-04-15 96,959 1,356,979 7.15

(click for more detail)

Similar Companies
AFL – Aflac Incorporated CNC – Centene Corporation
CNO – CNO Financial Group, Inc.


Financial data and stock pages provided by
Fintel.io